CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, V. W.
Right arrow Articles by Kirby, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, V. W.
Right arrow Articles by Kirby, T. J.

Canadian Journal of Anesthesia, Vol 38, 733-739, Copyright © 1991 by Canadian Anesthesiologists' Society


ARTICLES

Analgesic and pulmonary effects of continuous intercostal nerve block following thoracotomy

VW Chan, F Chung, DC Cheng, C Seyone, A Chung and TJ Kirby
Department of Anaesthesia, Toronto Western Division, Toronto Hospital, University of Toronto, Ontario, Canada.

This study examined the beneficial effects and potential systemic toxicity from continuous intercostal nerve block by repeated bolus injections of bupivacaine. In this double-blind, randomized study, 20 post-thoracotomy patients were assigned to receive four doses of either: 20 ml 0.5% bupivacaine with epinephrine 5 micrograms.ml-1 (bupivacaine group, n = 10), or 20 ml preservative-free saline (placebo group, n = 10) through two indwelling intercostal catheters every six hours. Patients receiving intercostal bupivacaine injections had greater decreases in visual analogue pain scores (VAS) (P less than 0.05) and lower 24 hr morphine requirements, 16.6 +/- 4.6 mg vs 35.8 +/- 7.2 mg, than patients in the placebo group (P less than 0.05). Higher post-injection values of forced expiratory volume in one second, forced vital capacity and peaked expiratory flow rate were also observed in the bupivacaine group (P less than 0.01). Repeated intercostal bupivacaine administration did lead to systemic accumulation, but the peak bupivacaine level after 400 mg was low at 1.2 +/- 0.2 microgram.ml-1. Thus, the technique of continuous intercostal nerve block described in this study is an effective treatment for the control of post-thoracotomy pain.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
G. P. Joshi, F. Bonnet, R. Shah, R. C. Wilkinson, F. Camu, B. Fischer, E. A. M. Neugebauer, N. Rawal, S. A. Schug, C. Simanski, et al.
A Systematic Review of Randomized Trials Evaluating Regional Techniques for Postthoracotomy Analgesia
Anesth. Analg., September 1, 2008; 107(3): 1026 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. C. Detterbeck
Efficacy of Methods of Intercostal Nerve Blockade for Pain Relief After Thoracotomy
Ann. Thorac. Surg., October 1, 2005; 80(4): 1550 - 1559.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
E. Cohen
Postthoracotomy Pain Management
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1999; 3(3): 156 - 167.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. S. Watson, S. Panian, V. Kendall, D. P. Maher, and G. Peters
Pain control after thoracotomy: bupivacaine versus lidocaine in continuous extrapleural intercostal nerve blockade
Ann. Thorac. Surg., March 1, 1999; 67(3): 825 - 828.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. Datta and S. Jain
Pain Management
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 264 - 277.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the Canadian Anesthesiologists' Society.